Does low glutathione worsen endothelial function?

Glutathione (GSH) is the most abundant non-protein thiol and the primary intracellular antioxidant, typically maintained at high concentrations (1–10 mM). It is a critical regulator of cellular redox homeostasis, particularly as we age, serving as the first line of defense against oxidative damage in the vascular system.

Mechanistic pathways

Glutathione maintains vascular health through both direct scavenging and enzymatic catalysis. It acts as a mandatory cofactor for the glutathione peroxidase (GPx) family, including GPX4, which specifically neutralizes lipid hydroperoxides to prevent ferroptotic cell death. When total glutathione levels are low, the capacity to neutralize reactive oxygen species (ROS), such as hydrogen peroxide and superoxide, is significantly diminished. In the endothelium, excess superoxide reacts rapidly with nitric oxide (NO) to form peroxynitrite. This "scavenging" of NO reduces its bioavailability, which is essential for vasodilation, and further impairs endothelial nitric oxide synthase (eNOS) function, creating a cycle of progressive vascular impairment.

Clinical evidence and vascular health

The clinical consequences of glutathione depletion are most evident in markers of vascular reactivity.

• Endothelial Function: Low GSH levels are strongly associated with reduced flow-mediated dilation (FMD), a gold-standard metric for endothelial health. This is particularly relevant in older adults and postmenopausal women, where GSH deficiency correlates with impaired endothelium-dependent dilation.
• Intervention Outcomes: Research indicates that restoring glutathione levels can reverse these deficits. Studies on precursors like GlyNAC (glycine and N-acetylcysteine) or combined glutathione and citrulline have shown significant improvements in FMD and a reduction in systemic oxidative stress markers like malondialdehyde (MDA).

Bottom line

Scientific evidence robustly supports the claim that glutathione is a critical intracellular antioxidant. Lower levels directly reduce the capacity to neutralize ROS, leading to diminished nitric oxide bioavailability and the worsening of endothelial dysfunction through increased oxidative stress and impaired vasodilation.